Psoriasis Plaque Elevation Should Be Most Important Cardinal Sign In Trials
Executive Summary
Psoriasis plaque elevation change should carry more weight than the two other cardinal signs for stable plaque psoriasis for treatments of the disease in clinical trials, FDA's Dermatologic and Ophthalmic Drugs Advisory Committee agreed at a March 20 meeting.